Neuromodulation in epilepsy: state-of-the-art approved therapies

P Ryvlin, S Rheims, LJ Hirsch, A Sokolov… - The Lancet …, 2021 - thelancet.com
Three neuromodulation therapies have been appropriately tested and approved in refractory
focal epilepsies: vagus nerve stimulation (VNS), deep brain stimulation of the anterior …

Transcutaneous vagus nerve stimulation-a brief introduction and overview

MJ Hilz - Autonomic Neuroscience, 2022 - Elsevier
Invasive cervical vagus nerve stimulation (VNS) is approved for the treatment of epilepsies,
depression, obesity, and for stroke-rehabilitation. The procedure requires surgery, has side …

Neurostimulation in generalized epilepsy: A systematic review and meta‐analysis

Z Haneef, HC Skrehot - Epilepsia, 2023 - Wiley Online Library
Objective There are three neurostimulation devices available to treat generalized epilepsy:
vagus nerve stimulation (VNS), deep brain stimulation (DBS), and responsive …

A comprehensive review of emerging trends and innovative therapies in epilepsy management

S Ghosh, JK Sinha, S Ghosh, H Sharma, R Bhaskar… - Brain Sciences, 2023 - mdpi.com
Epilepsy is a complex neurological disorder affecting millions worldwide, with a substantial
number of patients facing drug-resistant epilepsy. This comprehensive review explores …

Epilepsy and cognitive impairment in childhood and adolescence: a mini-review

FF Operto, GMG Pastorino, A Viggiano… - Current …, 2023 - benthamdirect.com
Managing epilepsy in people with an intellectual disability remains a therapeutic challenge
and must take into account additional issues such as diagnostic difficulties and frequent …

An overview of noninvasive brain stimulation: basic principles and clinical applications

A Bhattacharya, K Mrudula, SS Sreepada… - Canadian Journal of …, 2022 - cambridge.org
The brain has the innate ability to undergo neuronal plasticity, which refers to changes in its
structure and functions in response to continued changes in the environment. Although …

[HTML][HTML] Neuromodulation in drug resistant epilepsy

N Rincon, D Barr, N Velez-Ruiz - Aging and disease, 2021 - ncbi.nlm.nih.gov
Epilepsy affects approximately 70 million people worldwide, and it is a significant contributor
to the global burden of neurological disorders. Despite the advent of new AEDs, drug …

New advances in pharmacoresistant epilepsy towards precise management-from prognosis to treatments

C Xu, Y Gong, Y Wang, Z Chen - Pharmacology & Therapeutics, 2022 - Elsevier
Epilepsy, one of the most severe neurological diseases, is characterized by abrupt recurrent
seizures. Despite great progress in the development of antiseizure drugs (ASDs) based on …

Locus coeruleus modulates neuroinflammation in parkinsonism and dementia

FS Giorgi, F Biagioni, A Galgani, N Pavese… - International journal of …, 2020 - mdpi.com
Locus Coeruleus (LC) is the main noradrenergic nucleus of the central nervous system, and
its neurons widely innervate the whole brain. LC is severely degenerated both in …

Electrical stimulation for therapeutic approach

E Kim, S Kim, YW Kwon, H Seo, M Kim… - Interdisciplinary …, 2023 - Wiley Online Library
Electrical stimulation as a therapeutic approach is widely applicable in terms of target
tissues or target effects. This method can be an alternative to conventional therapies for …